We are live on
!
Find out more
WF
Welch & Forbes Portfolio holdings
AUM
$8.23B
1-Year Est. Return
17.62%
This Fund
S&P 500
This Quarter
Est. Return
+3.82%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.87B
AUM Growth
-$13.1M
(-0.34%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-3.37%
Top 10 Holdings %
Top 10 Hldgs %
23.72%
Holding
372
New
16
Increased
96
Reduced
171
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$7.62M |
| 2 |
Constellation Brands
STZ
|
+$4.4M |
| 3 |
CHX
ChampionX
CHX
|
+$3.45M |
| 4 |
Stanley Black & Decker
SWK
|
+$3.4M |
| 5 |
Valero Energy
VLO
|
+$2.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$41.6M |
| 2 |
Check Point Software Technologies
CHKP
|
+$11.3M |
| 3 |
Medtronic
MDT
|
+$9.78M |
| 4 |
Franklin Resources
BEN
|
+$8.22M |
| 5 |
CELG
Celgene Corp
CELG
|
+$7.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.99% |
| 2 | Technology | 17.92% |
| 3 | Financials | 11.59% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $2.84M | 0.07% |
65,572
-3,110
| -5% | -$144K |
|
152
Invesco Senior Loan ETF
BKLN
$6.97B
| $2.84M | 0.07% |
123,885
-177,840
| -59% | -$4.1M |
|
153
NextEra Energy
NEE
$183B
| $2.83M | 0.07% |
67,800
-944
| -1% | -$38.1K |
|
154
Newell Brands
NWL
$2.18B
| $2.74M | 0.07% |
106,395
+17,891
| +20% | +$466K |
|
155
Alliant Energy
LNT
$18.3B
| $2.57M | 0.07% |
60,700
| – | – |
|
156
Moody's
MCO
$83.5B
| $2.57M | 0.07% |
15,048
-1,370
| -8% | -$232K |
|
157
Dentsply Sirona
XRAY
$2.75B
| $2.52M | 0.07% |
57,667
-188
| -0.3% | -$8.83K |
|
158
Cigna
CI
$76.1B
| $2.51M | 0.06% |
14,779
| – | – |
|
159
Mastercard
MA
$510B
| $2.49M | 0.06% |
12,655
+90
| +0.7% | +$16.9K |
|
160
Illinois Tool Works
ITW
$81.6B
| $2.38M | 0.06% |
17,207
+60
| +0.3% | +$8.88K |
|
|
MUI
161
DELISTED
BlackRock Municipal Income Fund, Inc.
MUI
| $2.36M | 0.06% |
178,495
-65,000
| -27% | -$851K |
|
162
Vanguard Short-Term Bond ETF
BSV
$44.7B
| $2.35M | 0.06% |
30,114
-50
| -0.2% | -$3.91K |
|
163
iShares Gold Trust
IAU
$63.8B
| $2.35M | 0.06% |
97,571
-500
| -0.5% | -$12.5K |
|
164
Biogen
BIIB
$30.7B
| $2.31M | 0.06% |
7,940
+56
| +0.7% | +$15.7K |
|
165
iShares MSCI EAFE ETF
EFA
$78.5B
| $2.24M | 0.06% |
33,481
-2,547
| -7% | -$179K |
|
166
Lowe's Companies
LOW
$118B
| $2.23M | 0.06% |
23,315
-39
| -0.2% | -$3.53K |
|
167
iShares Select Dividend ETF
DVY
$23.6B
| $2.12M | 0.05% |
21,695
+175
| +0.8% | +$17K |
|
168
Masco
MAS
$14.2B
| $2.07M | 0.05% |
55,282
-15,675
| -22% | -$603K |
|
169
Vanguard S&P 500 ETF
VOO
$972B
| $2.05M | 0.05% |
8,200
| – | – |
|
|
VAR
170
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.85M | 0.05% |
16,273
-2,449
| -13% | -$293K |
|
|
STI
171
DELISTED
SunTrust Banks, Inc.
STI
| $1.76M | 0.05% |
26,648
+20
| +0.1% | +$1.36K |
|
172
Philip Morris
PM
$299B
| $1.74M | 0.04% |
21,493
-925
| -4% | -$78.5K |
|
173
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $1.72M | 0.04% |
44,190
+1,375
| +3% | +$53.1K |
|
174
Honeywell
HON
$76.7B
| $1.69M | 0.04% |
12,999
+3,609
| +38% | +$480K |
|
175
MetLife
MET
$62.5B
| $1.63M | 0.04% |
37,365
-42,495
| -53% | -$1.98M |
|
Similar funds
OC
LGF
CCM
CL
WJWM
WA
GGHC
CCM
Welch & Forbes's Q2 2018 Portfolio in Review
As of Q2 2018, Welch & Forbes held 372 positions worth $3.87B, down 0.34% from $3.88B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Welch & Forbes withdrew a net $131M in Q2 2018, closing 13 positions and reducing 171 holdings. Its most notable exit was Chubb, an estimated $41.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Welch & Forbes opened a new position in ChampionX worth $3.52M.
- Welch & Forbes's largest Q2 2018 buy was ChampionX: 84,371 shares worth $3.52M.
- Welch & Forbes added most to Thermo Fisher Scientific in Q2 2018, an estimated $7.62M increase.
- Welch & Forbes's biggest Q2 2018 reduction was Franklin Resources, cutting an estimated $8.22M.
- Welch & Forbes fully exited Chubb in Q2 2018, selling an estimated $41.6M.
- Welch & Forbes's ten largest holdings make up 24% of its $3.87B portfolio in Q2 2018.
- Welch & Forbes opened 16 new positions and closed 13 in Q2 2018.
- Welch & Forbes's portfolio value fell 0.34% quarter-over-quarter to $3.87B.
Based on Welch & Forbes's 13F filing for Q2 2018, filed 16 Jul 2018.